NEW YORK (TheStreet) -- Shares of Amedisys Inc.
(AMED) are spiking 29% to $20.73 today following the health care company's higher than expected second quarter earnings, helped by the closing some of its hospices and home health care centers to reduce costs.
Adjusted net income for the second quarter rose to $8 million, or 25 cents per share, up from $5.8 million, or 18 cents per share, a year earlier and beating the consensus estimate of 4 cents by 21 cents.
Revenue fell -3.5% year-over-year to $305 million, compared to the $316 million in the same quarter of 2013, but ahead of analysts' estimate of $289.9 million.
AMED data by YCharts
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts